The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010

Prevalence and Predictors of Potential Drug-Drug Interactions in the Elderly: A Cross-Sectional Study in the Brazilian Primary Public Health System

(2016) Paulo Roque Obreli Neto et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM–Elderly Project 2000–2010

(2014) Carlotta Franchi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity

(2012) L. D. Hughes et al.   AGE AND AGEING

Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes

(2012) Bhavik M. Shah et al.   CLINICS IN GERIATRIC MEDICINE

External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?

(2012) C. Saunders et al.   DIABETIC MEDICINE

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

(2012) Karen Barnett et al.   LANCET

Adapting clinical guidelines to take account of multimorbidity

(2012) B. Guthrie et al.   BMJ-British Medical Journal

Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan

(2011) Chen-Fang Lin et al.   DRUGS & AGING

Managing Medications in Clinically Complex Elders

(2010) Michael A. Steinman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adverse drug events in the outpatient setting: an 11-year national analysis

(2010) Florence T. Bourgeois et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database

(2009) A. Nobili et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS